AI assistant
CARYSIL LIMITED — Capital/Financing Update 2025
Nov 10, 2025
61456_rns_2025-11-10_44fdcc48-5a2a-482b-bb6f-f1796142ba82.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [188 x 146] intentionally omitted <==
November 10, 2025
To, To, BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1 Phiroze Jeejeebhoy Towers, 'G' Block, Bandra – Kurla Complex Dalal Street, Bandra East, Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 524091 Trading Symbol: CARYSIL
Sub: Monitoring Agency Report issued by ICRA Limited for the utilization of funds raised through Qualified Institutions Placement for quarter ended September 30, 2025
In compliance with Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Monitoring Agency Report for the quarter ended September 30, 2025. This report has been issued by ICRA Limited, the Monitoring Agency appointed by the Company, to monitor the utilization of funds raised through the Qualified Institutions Placement (QIP).
You are requested to take the same on record.
Thanking you, Yours Faithfully,
For CARYSIL LIMITED
REENA Digitally signed by REENA TEJAS TEJAS SHAH Date: 2025.11.10 SHAH 14:21:16 +05'30' REENA SHAH COMPANY SECRETARY & COMPLIANCE OFFICER
Encl.: a/a
==> picture [141 x 76] intentionally omitted <==
==> picture [115 x 54] intentionally omitted <==
ICRA Limited
Date: November 10, 2025
Ms. Reena Shah Company Secretary and Compliance Officer
Carysil Limited
Survey No. 312, Navagam Vartej 364060 Bhavnagar, (Gujarat) India
Dear Ma’am,
Re: Final Monitoring Agency report of Carysil Limited for Q2 FY2026
Please refer to agreement dated July 01, 2024, appointing ICRA Limited as the Monitoring Agency (MA) for Carysil Limited’s QIP Issue.
After due consideration, ICRA has prepared the attached final Monitoring Agency report as per SEBI (Issue of Capital and Disclosure Requirements) Regulations for Q2 FY2026.
Please note that the Monitoring Agency report does not constitute a commentary on the quality of the objects of the issue, appropriateness or reasonableness of costs or spending by Carysil Limited against any objects / heads or assurance on outcome of such spending.
We thank you for your kind cooperation extended during the course of Q2 FY2026. Should you require any clarification, please do not hesitate to get in touch with us.
We look forward to your communication and assure you of our best services.
With kind regards
For ICRA Limited
Digitally signed PARUL by PARUL GOYAL GOYAL NARANG Date: NARANG 2025.11.10 10:44:37 +05'30'
Parul Goyal Narang Vice President & Head- Process Excellence [email protected]
Building No. 8, 2[nd] Floor, Tower A DLF Cyber City, Phase II Gurugram – 122002, Haryana
Tel.: +91.124 .4545300 CIN : L749999DL1991PLC042749
Website: www.icra.in Email: [email protected] Helpdesk: +91 9354738909
Registered Office: B-710, Statesman House, 148, Barakhamba Road, New Delhi 110001. Tel. :+91.11.23357940-41
RATING ● RESEARCH ● INFORMATION
Sensitivity Label : Internal
September 2025
MONITORING AGENCY REPORT
Name of the Issuer: Carysil Limited For quarter ended: September 30, 2025
Name of the Monitoring Agency: ICRA Limited
- (a) Deviation from the objects of the issue:
No material deviation - the utilization of the issuance proceeds is in line with the objects of the issue.
- (b) Range of deviation:
Not Applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that we do not perceive any conflict of interest in such relationship/ interest while monitoring and reporting the utilization of the issue proceeds by the issuer. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.
Signature:
PARUL Digitally signed by PARUL GOYAL GOYAL NARANG NARAN Date: 2025.11.10 G 10:43:54 +05'30'
Parul Goyal Narang Vice President & Head-Process Excellence
Analyst: Sweety Shaw QA: Dhwani Vinchhi
1
September 2025
1. Issuer Details
Name of the Issuer : Carysil Limited Name(s) of the promoters:
Promoters
Mr. Chirag Ashwinbhai Parekh Ms. Shetal Chirag Parekh Source: Letter of Offer
Industry/ sector to which it belongs : Manufacturing and selling kitchen sinks, kitchen appliances, faucets, wash basins, WC, tiles, etc.
2. Issue Details
Issue Period : Opening date- July 01, 2024
Closing date- July 03, 2024
Type of Issue : QIP Issue
Type of specified securities : Equity shares
Issue Size (Rs. Crore): 125.00 Crore
With OFS portion: Not Applicable; Excluding OFS portion: Not Applicable.
Net Proceeds as per prospectus: INR 121.70 Crore (Excluding Issue Related Expenses amounting INR 3.30 crore)
*Net proceeds have been revised at INR 121.65 Crore owing to Issue related expenses (IRE) being higher by 0.05 crore as on 30th September 2025.
2
September 2025
3. Details of the arrangement made to ensure the monitoring of issue proceeds.
| Particulars | Reply | Source of information, certifications considered by the Monitoring Agency for the preparation of report |
Comments of the Monitoring Agency |
Comments of the Issuer’s Board of Directors |
|
|---|---|---|---|---|---|
| Whether all utilization is as per the disclosures in the Offer Document? |
Yes | -Offer Letter - Confirmation from management -Bank statement of the proceeds accounts and corresponding account -Peer Reviewed CA Certificate |
The net proceeds have been revised to INR 121.65 Crore owing to issue related expenses (IRE) being higher by 0.05 crore |
No Comments | |
| Whether shareholder approval has been obtained in case of material deviations#from expenditures disclosed in the Offer Document? |
NA | As confirmed by the Issuer’s management |
No comments | No comments | |
| Whether the means of finance for the disclosed objects of the issue has changed? |
No | As confirmed by the Issuer’s management |
No comments | No comments | |
| Is there any major deviation observed over the earlier monitoring agency reports? |
No | No deviation observed | No comments | No comments | |
| Whether all Government/ statutory approvals related to the object(s) have been obtained? |
Yes | As confirmed by the Issuer’s management |
No comments | No comments | |
| Whether all arrangements pertaining to technical assistance/ collaboration are in operation? |
Yes | As confirmed by the Issuer’s management |
No comments | No comments | |
| Are there any favorable events improving the viability of these object(s)? |
No | As confirmed by the Issuer’s management |
As understood from the Issuer’s management |
No comments | |
| Are there any unfavorable events affecting the viability of the object(s)? |
No | As confirmed by the Issuer’s management |
As understood from the Issuer’s management |
No comments | |
| Is there any other relevant | No | As understood from the Issuer’s | No comments |
3
September 2025
| Particulars | Reply | Source of information, certifications considered by the Monitoring Agency for the preparation of report |
Comments of the Monitoring Agency |
Comments of the Issuer’s Board of Directors |
|---|---|---|---|---|
| information that may materially affect the decision making of the investors? |
As confirmed by the Issuer’s management |
management |
4
September 2025
4. Details of the object(s) to be monitored.
(i) Cost of object(s)
| S.N. | Item Head | Source of information, certifications considered by the Monitoring Agency for the preparation of report |
Original cost (as per the offer document) [Rs. Crore] |
Revised cost [Rs. Crore] |
Comments of the Monitoring Agency |
Comments of the Issuer’s Board of Directors |
Comments of the Issuer’s Board of Directors |
Comments of the Issuer’s Board of Directors |
|---|---|---|---|---|---|---|---|---|
| Reason for cost revision |
Propos ed financi ng option |
Particulars of firm arrangements made |
||||||
| 1 | Funding the capital expenditure towards procurement and installation of machines, equipment and moulds required for the /or new manufacturing _facility(ies). _ |
Offer Letter | 62.50 | Not Applicable |
No comments | N.A. | N.A. | N.A. |
| 2 | Funding the company’s working capital requirements |
Offer Letter | 31.25 | Not Applicable |
No comments | N.A. | N.A. | N.A. |
| 3 | General corporate purposes |
Offer Letter | 27.95 | 27.90 | revision in the general corporate purpose is due to an increase in issue-related expenses (IRE) by INR 0.05 crore |
N.A. | N.A. | N.A. |
| Total | 121.70 | 121.65 |
5
September 2025
(ii) Progress in the object(s)
| S.N. | Item Head* | Source of information, certifications considered by the Monitoring Agency for the preparation of report |
Amount as proposed in the offer document [Rs. Crore] |
Amount utilized [Rs. Crore] |
Amount utilized [Rs. Crore] |
Amount utilized [Rs. Crore] |
Total unutilized t |
Comments of the Monitoring Agency |
Comments of the Issuer’s Board of Directors |
Comments of the Issuer’s Board of Directors |
|---|---|---|---|---|---|---|---|---|---|---|
| As at the beginning of the quarter |
Reasons for idle funds |
Proposed course of action |
||||||||
| Di | At th | |||||||||
| e | amoun [R |
|||||||||
| urng th |
d f | |||||||||
| en o | s. C] |
|||||||||
| e t |
th | |||||||||
| e | rore | |||||||||
| quarer | quarter | |||||||||
| 1 | Funding the capital expenditure towards procurement and installation of machines, equipment and moulds required for the /or new manufacturing facility(ies). |
-Offer Letter -Bank statement of the proceeds accounts and corresponding accounts -Peer Reviewed CA Certificate |
62.50 | 14.52 | 3.27 | 17.79 | 44.71 | No comments |
No comments |
No comments |
| 2 | Funding the company’s working capital requirements |
Same as above |
31.25 | 31.25 | - | 31.25 | NIL | No comments |
No comments |
No comments |
| 3 | General corporate purposes |
Same as above |
27.90 | 27.90 | - | 27.90 | NIL | No comments |
No comments |
No comments |
| Total | 121.65 | 73.67 | 3.27 | 76.94 | 44.71 |
Note: Revised cost as per point no 4(i) above.
6
September 2025
(iii) Deployment of unutilized proceeds
| S.N. | Type of instrument and name of the entity invested in |
Amount invested [Rs. Crore] |
Maturity date | Earning [Rs. Crore] |
Return on Investment [%] |
Market Value as at the end of quarter [Rs. Crore] |
|---|---|---|---|---|---|---|
| 1 | Fixed Deposit with HDFC Bank Account Number- 50301173263133 |
2.000 | 11th Sep 2026 | 0.010 | 6.60% | 2.010 |
| 2 | Fixed Deposit with HDFC Bank Account Number- 50301205844237 |
2.500 | 24th Aug 2026 | 0.010 | 6.25% | 2.510 |
| 3 | Fixed Deposit with HDFC Bank Account Number- 50301206537990 |
2.500 | 31st Aug 2026 | 0.020 | 6.25% | 2.520 |
| 4 | Fixed Deposit with HDFC Bank Account Number- 50301207021128 |
2.500 | 1stSep 2026 | 0.020 | 6.25% | 2.520 |
| 5 | Fixed Deposit with HDFC Bank Account Number- 50301207813386 |
2.500 | 4th Sep 2026 | 0.020 | 6.25% | 2.520 |
| 6 | Fixed Deposit with HDFC Bank Account Number- 50301208311723 |
2.500 | 9th Sep 2026 | 0.010 | 6.25% | 2.510 |
| 7 | Fixed Deposit with HDFC Bank Account Number- 50301208936925 |
2.500 | 14th Sep 2026 | 0.010 | 6.25% | 2.510 |
| 8 | Fixed Deposit with HDFC Bank Account Number- 50301211032341 |
2.500 | 25th Nov 2026 | 0.010 | 6.25% | 2.510 |
| 9 | Fixed Deposit with HDFC Bank Account Number- 50301210243057 |
2.500 | 20th Nov 2026 | 0.010 | 6.25% | 2.510 |
| 10 | Fixed Deposit with HDFC Bank Account Number- 50301211454363 |
2.500 | 30th Nov 2026 | 0.010 | 6.25% | 2.510 |
| 11 | Fixed Deposit with HDFC Bank Account Number- 50301212003531 |
2.500 | 5th Dec 2026 | 0.010 | 6.35% | 2.510 |
| 12 | Fixed Deposit with HDFC Bank Account Number- 50301212551702 |
2.500 | 10th Dec 2026 | 0.010 | 6.35% | 2.510 |
| 13 | Fixed Deposit with HDFC Bank Account Number- |
2.500 | 20th Feb 2027 | 0.010 | 6.35% | 2.510 |
7
September 2025
| 50301213015198 | ||||||
|---|---|---|---|---|---|---|
| 14 | Fixed Deposit with HDFC Bank Account Number- 50301214550946 |
2.500 | 25th Feb 2027 | 0.010 | 6.35% | 2.510 |
| 15 | Fixed Deposit with HDFC Bank Account Number- 50301215102014 |
2.500 | 2nd Mar 2027 | 0.010 | 6.35% | 2.510 |
| 16 | Fixed Deposit with HDFC Bank Account Number- 50301215509086 |
2.500 | 7th Mar 2027 | 0.010 | 6.35% | 2.510 |
| 17 | Balance in HDFC Monitoring Account- 57500001522173 |
0.006 | - | - | - | 0.006 |
| 18 | Balance in the Current Account with Citi Bank-001 |
5.210 | - | - | - | 5.210 |
| Total | 44.716 | 0.190 | 44.906 |
Source: As certified by Park & Company
(iv) Delay in the implementation of the object(s)
| Completion date | Completion date | Comments of the Issuer’s Board of Directors |
Comments of the Issuer’s Board of Directors |
||
|---|---|---|---|---|---|
| Object(s) | As per the offer document |
Actual^ | Delay [Number of days or months] |
Reason for delay | Proposed course of action |
| Funding the capital expenditure towards procurement and installation of machines, equipment and moulds required for the /or new manufacturing facility(ies) |
-INR 37.50 crore in fiscal year ended 31st March 2025 - INR 25.00 crore in fiscal year ended 31st March 2026 |
-INR 7.41 crore has been utilized till the fiscal year ended 31st March 2025 -INR 17.79 crore has been utilized till 30th September 2025 |
INR 44.71 crore is expected to be utilized by fiscal year ended 31st March 2026 |
No Comments | No Comments |
| Funding the company’s working capital requirements |
-INR 31.25 crore in fiscal year ended 31st March 2025 |
On Schedule | N.A. | No Comments | No Comments |
| General corporate purposes |
-INR 27.90* crore in fiscal year ended 31st March 2025 |
On Schedule | N.A. | No Comments | No Comments |
Source: As confirmed by the Issuer’s management
* Revision in the amount of general corporate purpose at INR 27.90 crore is on account of issue related expenses (IRE) have increased by INR 0.05 crore.
8
September 2025
5. Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document
| S.N. | Item Head | Amount [Rs. Crore] |
Source of information, certifications considered by the Monitoring Agency for the preparation of report |
Comments of the Monitoring Agency |
Comments of the Issuer’s Board of Directors |
|---|---|---|---|---|---|
| 1 | Advertising & Publicity Expenses |
2.22* | -Bank statement of the proceeds accounts and corresponding account -Peer Reviewed CA Certificate |
No Comments | No Comments |
| 2 | Acrysil USA Loan Payment | 2.81^ | Same As Above | No Comments | No Comments |
| 3 | Raising Funds-Right Issue CSL | 4.25^ | Same As Above | No Comments | No Comments |
| 4 | Supplier’s Payment | 18.20^ | Same As Above | No Comments | No Comments |
| 5 | Sales Promotion Expenses | 0.42^ | Same As Above | No Comments | No Comments |
| Total | 27.90 |
-
The said utilization was made in Q3 FY2025
-
^ The said utilization was made in Q4 FY2025
9